PET/CT accurately predicts MCL stageAugust 2, 2018Mantle Cell LymphomaAggressive LymphomasB Cell Lymphoma
Late mortality risk after childhood BMT is substantial, persistentJuly 28, 2018Hodgkin LymphomaIndolent LymphomaMantle Cell Lymphoma
Bortezomib plus vorinostat shows modest response in MCLJune 29, 2018Mantle Cell LymphomaAggressive LymphomasB Cell Lymphoma
British good practice paper offers MCL diagnosis pearlsJune 15, 2018Mantle Cell LymphomaAggressive Lymphomas
Ibrutinib plus venetoclax is active in mantle cell lymphomaMarch 28, 2018Mantle Cell LymphomaAggressive Lymphomas
Outpatient CAR T infusions feasible using liso-celMarch 12, 2018Aggressive LymphomasCellular TherapyMantle Cell Lymphoma
Ibrutinib linked to invasive fungal infectionsMarch 7, 2018CLLPatient & Survivor CareIndolent LymphomaMantle Cell Lymphoma
Acalabrutinib shows less off-target activity in mantle cell lymphomaMarch 2, 2018Mantle Cell LymphomaAggressive Lymphomas
NF-kappaB pathway could help solve resistance problem in mantle cell lymphomaFebruary 16, 2018Mantle Cell LymphomaAggressive Lymphomas
